Cargando…
Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View
Background: The concept of metabolic syndrome (MetSy) brings together components that individually represent a risk factor for cardiovascular diseases, which over time can prove to be more harmful if a combined effect of these is exhibited. Method: A single-centre retrospective study in an academic...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377522/ https://www.ncbi.nlm.nih.gov/pubmed/37509651 http://dx.doi.org/10.3390/biomedicines11072012 |
_version_ | 1785079538469830656 |
---|---|
author | Rosca, Ciprian Ilie Lighezan, Daniel Florin Nisulescu, Daniel-Dumitru Sharma, Abhinav Neagu, Marioara Nicula Nistor, Daciana Georgescu, Doina Kundnani, Nilima Rajpal |
author_facet | Rosca, Ciprian Ilie Lighezan, Daniel Florin Nisulescu, Daniel-Dumitru Sharma, Abhinav Neagu, Marioara Nicula Nistor, Daciana Georgescu, Doina Kundnani, Nilima Rajpal |
author_sort | Rosca, Ciprian Ilie |
collection | PubMed |
description | Background: The concept of metabolic syndrome (MetSy) brings together components that individually represent a risk factor for cardiovascular diseases, which over time can prove to be more harmful if a combined effect of these is exhibited. Method: A single-centre retrospective study in an academic medical unit was conducted. We analysed the link between the MetSy and the occurrence of neuropsychic complications among atrial fibrillation (AF) patients. We sifted through the files of the patients admitted during 2015–2016 to the Municipal Emergency University Hospital Timisoara, Romania, with the diagnosis of AF. We divided these AF patients into two groups: the first group comprised patients with atrial fibrillation and MetSy (267 patients), while the second group comprised AF patients without MetSy (843 patients). We analysed the occurrence of neuropsychic changes (stroke, Parkinson’s disease, dementia, cognitive impairment, and silent lacunar infarction) among the two groups. Results: Cognitive impairment (p-value = 0.0081) and dementia (p-value < 0.0001) were less frequent in patients with AF and MetSy than in those with AF without MetSy. Regarding the presence of stroke and Parkinson’s disease (PD), we could not demonstrate the existence of any statistically significant difference between the two groups. Using logistic regression (enter test), we found that MetSy might have a protective effect (OR = 0.4040, 95% CI [0.2132; 0.7654], p-value = 0.0054) for the occurrence of dementia in those patients. Furthermore, obesity was the only factor with a possible protective effect from all the constituents of the MetSy when analysed together (with a significance level of p-value = 0.0004 for the logistic regression). The protective effect of MetSy against stroke occurrence was supplementarily proven by a longer period of survival without stroke from the AF diagnosis (3.521 years, p = 0.0304) compared to patients with AF without MetSy (3.286 years to first stroke occurrence). Conclusions: Metabolic syndrome might offer protection against the occurrence of dementia among patients with AF, but no effect was noted when compared with the presence of stroke. Further studies on larger cohorts can help us reach a conclusion regarding the positive effects of the metabolic syndrome. |
format | Online Article Text |
id | pubmed-10377522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103775222023-07-29 Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View Rosca, Ciprian Ilie Lighezan, Daniel Florin Nisulescu, Daniel-Dumitru Sharma, Abhinav Neagu, Marioara Nicula Nistor, Daciana Georgescu, Doina Kundnani, Nilima Rajpal Biomedicines Article Background: The concept of metabolic syndrome (MetSy) brings together components that individually represent a risk factor for cardiovascular diseases, which over time can prove to be more harmful if a combined effect of these is exhibited. Method: A single-centre retrospective study in an academic medical unit was conducted. We analysed the link between the MetSy and the occurrence of neuropsychic complications among atrial fibrillation (AF) patients. We sifted through the files of the patients admitted during 2015–2016 to the Municipal Emergency University Hospital Timisoara, Romania, with the diagnosis of AF. We divided these AF patients into two groups: the first group comprised patients with atrial fibrillation and MetSy (267 patients), while the second group comprised AF patients without MetSy (843 patients). We analysed the occurrence of neuropsychic changes (stroke, Parkinson’s disease, dementia, cognitive impairment, and silent lacunar infarction) among the two groups. Results: Cognitive impairment (p-value = 0.0081) and dementia (p-value < 0.0001) were less frequent in patients with AF and MetSy than in those with AF without MetSy. Regarding the presence of stroke and Parkinson’s disease (PD), we could not demonstrate the existence of any statistically significant difference between the two groups. Using logistic regression (enter test), we found that MetSy might have a protective effect (OR = 0.4040, 95% CI [0.2132; 0.7654], p-value = 0.0054) for the occurrence of dementia in those patients. Furthermore, obesity was the only factor with a possible protective effect from all the constituents of the MetSy when analysed together (with a significance level of p-value = 0.0004 for the logistic regression). The protective effect of MetSy against stroke occurrence was supplementarily proven by a longer period of survival without stroke from the AF diagnosis (3.521 years, p = 0.0304) compared to patients with AF without MetSy (3.286 years to first stroke occurrence). Conclusions: Metabolic syndrome might offer protection against the occurrence of dementia among patients with AF, but no effect was noted when compared with the presence of stroke. Further studies on larger cohorts can help us reach a conclusion regarding the positive effects of the metabolic syndrome. MDPI 2023-07-17 /pmc/articles/PMC10377522/ /pubmed/37509651 http://dx.doi.org/10.3390/biomedicines11072012 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rosca, Ciprian Ilie Lighezan, Daniel Florin Nisulescu, Daniel-Dumitru Sharma, Abhinav Neagu, Marioara Nicula Nistor, Daciana Georgescu, Doina Kundnani, Nilima Rajpal Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View |
title | Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View |
title_full | Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View |
title_fullStr | Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View |
title_full_unstemmed | Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View |
title_short | Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View |
title_sort | metabolic syndrome: a strange companion of atrial fibrillation; a blessing in disguise from the neuropsychiatric point of view |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377522/ https://www.ncbi.nlm.nih.gov/pubmed/37509651 http://dx.doi.org/10.3390/biomedicines11072012 |
work_keys_str_mv | AT roscaciprianilie metabolicsyndromeastrangecompanionofatrialfibrillationablessingindisguisefromtheneuropsychiatricpointofview AT lighezandanielflorin metabolicsyndromeastrangecompanionofatrialfibrillationablessingindisguisefromtheneuropsychiatricpointofview AT nisulescudanieldumitru metabolicsyndromeastrangecompanionofatrialfibrillationablessingindisguisefromtheneuropsychiatricpointofview AT sharmaabhinav metabolicsyndromeastrangecompanionofatrialfibrillationablessingindisguisefromtheneuropsychiatricpointofview AT neagumarioaranicula metabolicsyndromeastrangecompanionofatrialfibrillationablessingindisguisefromtheneuropsychiatricpointofview AT nistordaciana metabolicsyndromeastrangecompanionofatrialfibrillationablessingindisguisefromtheneuropsychiatricpointofview AT georgescudoina metabolicsyndromeastrangecompanionofatrialfibrillationablessingindisguisefromtheneuropsychiatricpointofview AT kundnaninilimarajpal metabolicsyndromeastrangecompanionofatrialfibrillationablessingindisguisefromtheneuropsychiatricpointofview |